LMR Partners’s AbbVie ABBV Stock Holding History

LMR Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,900	Closed	-$1.58M	–	1419
2025 Q4	$1.58M	Hold	6,900	–	–	﹤0.01%	872
2025 Q3	$1.6M	Buy	6,900 +4,500	+188%	+$916K	0.01%	799
2025 Q2	$445K	Sell	2,400 -17,900	-88%	-$3.33M	﹤0.01%	977
2025 Q1	$4.25M	Buy	+20,300	New	+$3.95M	0.04%	466
2024 Q2	–	Sell	-25,600	Closed	-$4.66M	–	1086
2024 Q1	$4.66M	Hold	25,600	–	–	0.05%	345
2023 Q4	$3.97M	Buy	+25,600	New	+$3.73M	0.05%	356

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LMR Partners's ABBV Position: Q1 2026 in Review

LMR Partners sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 59 shares — an estimated $13.5K sold.

LMR Partners first reported a position in ABBV in Q3 2014 and held it in 28 quarters. The position peaked at $9.46M in Q3 2015. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

LMR Partners reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
LMR Partners sold 59 AbbVie shares in Q1 2026, an estimated $13.5K.
LMR Partners first reported a position in AbbVie in Q3 2014 and held it in 28 quarters.
LMR Partners's AbbVie position peaked at $9.46M in Q3 2015.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.